Recent Updates
Recently added Catalysts
AMGN

Amgen To Present At The UBS Global Life Sciences Conference Amgen (NASDAQ:AMGN) will participate in the UBS Global Life Sciences Conference on Tuesday, May 21, 2013, at the Sheraton New York Times Square in...

Key Takeaway: THOUSAND OAKS, Calif. , May 16, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the UBS Global Life Sciences Conference on Tuesday, May 21, 2013 , at the Sheraton New York Times Square in New York City , beginning at 10:00 a.m. Eastern Daylight Time . Joseph P. Mil

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , May 16, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the UBS Global Life Sciences Conference on Tuesday, May 21, 2013 , at the Sheraton New York Times Square in New York City , beginning at 10:00 a.m. Eastern Daylight Time . Joseph P. Miletich , M.D., Ph.D., senior vice president of Research and Development at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.
CONTACT: Amgen, Thousand Oaks Ashleigh Koss , 805-313-6151 (media) Arvind Sood , 805-447-1060 (investors)
Last updated: May 16, 2013